A study of the short-term gait improvement effect using a biological signal reaction type motor function improvement device for gait instability in patients with Parkinson's disease. a randomized controlled trial

Kohara Nobuo0 个研究点目标入组 30 人开始时间: 2023年6月20日最近更新: 2023年11月20日

适应症

试验速览

暂无简介。

•1)Those who have been diagnosed with clinically established or clinically probable cases according
•to the clinical diagnostic criteria for Parkinson's disease by the Movement Disorder Society (MDS).
•2)Hoehn-Yahr Scale stage III
•3)Those who have not changed the type and dos e of Parkinson's drug before 4 weeks of the date o f consent acquisition and have no plans to change it while participating in clinical research.
•4)Those who do not have a clear wearing-off phe nomenon.
•5)Those who are judged by the doctor that their g eneral condition is stable and that standing / walki ng training can be carried out.
•6)Those who can stand up and sit and walk 10 m or more without assistance (regardless of the use of assistive devices).
•7)Those who are 20 years old or older at the time of consent
•8)Those who have obtained the document conse nt of the subject.
•9)Those who meet the following conditions descri bed in the HAL package insert
•a)Weight 40-100kg
•b)Those who can wear HAL with a height of about 150 to 190 cm or a body size such as thigh length, lower leg length, and waist width.
•10) Those who can about21-day rehabilitation hos
•pitalization for PD.

•1)Those who the doctor judges to be inappropriat e, such as improper standing and walking training 2)Those who have difficulty wearing HAL due to p hysical deformation, etc.
•3)Those who have difficulty in attaching electrode s due to skin diseases, etc.
•4)Those who are pregnant
•5)Those who have a cognitive function test (MMS
•E) of 23 points or less.
•6)In addition, those who are judged to be inappro priate for conducting this research by the principal investigator or the other investigator.

发起方

Kohara Nobuo